Apogee Therapeutics, Inc. (APGE)
134.81
+0.06
(+0.04%)
USD |
NASDAQ |
Aug 24, 16:00
134.81
0.00 (0.00%)
After-Hours: 18:21
Apogee Therapeutics 1 Year Total Returns (Daily) : 270.7% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 270.7% |
| August 20, 2026 | 274.1% |
| August 19, 2026 | 270.0% |
| August 18, 2026 | 264.7% |
| August 17, 2026 | 260.9% |
| August 14, 2026 | 253.0% |
| August 13, 2026 | 259.9% |
| August 12, 2026 | 266.6% |
| August 11, 2026 | 288.7% |
| August 10, 2026 | 280.5% |
| August 07, 2026 | 274.6% |
| August 06, 2026 | 270.3% |
| August 05, 2026 | 250.2% |
| August 04, 2026 | 260.3% |
| August 03, 2026 | 255.3% |
| July 31, 2026 | 250.5% |
| July 30, 2026 | 257.1% |
| July 29, 2026 | 253.8% |
| July 28, 2026 | 238.3% |
| July 27, 2026 | 229.0% |
| July 24, 2026 | 222.5% |
| July 23, 2026 | 230.9% |
| July 22, 2026 | 238.6% |
| July 21, 2026 | 243.1% |
| July 20, 2026 | 241.3% |
| Date | Value |
|---|---|
| July 17, 2026 | 243.6% |
| July 16, 2026 | 249.4% |
| July 15, 2026 | 261.6% |
| July 14, 2026 | 244.5% |
| July 13, 2026 | 250.9% |
| July 10, 2026 | 246.5% |
| July 09, 2026 | 260.8% |
| July 08, 2026 | 266.0% |
| July 07, 2026 | 240.3% |
| July 06, 2026 | 181.3% |
| July 02, 2026 | 199.9% |
| July 01, 2026 | 200.0% |
| June 30, 2026 | 205.6% |
| June 29, 2026 | 205.7% |
| June 26, 2026 | 202.6% |
| June 25, 2026 | 208.6% |
| June 24, 2026 | 204.7% |
| June 23, 2026 | 221.4% |
| June 22, 2026 | 215.9% |
| June 18, 2026 | 119.5% |
| June 17, 2026 | 112.3% |
| June 16, 2026 | 100.0% |
| June 15, 2026 | 93.77% |
| June 12, 2026 | 111.0% |
| June 11, 2026 | 110.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cogent Biosciences, Inc. | 212.1% |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |
| Intellia Therapeutics, Inc. | 26.81% |
| Revolution Medicines, Inc. | 474.2% |
| Erasca, Inc. | 1.08K% |